QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced Panels
QIAstat-Dx Rise, which can process up to 56 tests in an eight-hour shift with enhanced walk-away efficiency, receives CE-marking to run new respiratory and gastrointestinal panels QIAstat-Dx Respiratory SARS-CoV-2 Panel with CE-marking expanded to 23 pathogens, now includes Chlamydophila pneumoniae to detect bacteria that is major cause of respiratory infections QIAstat-Dx Gastrointestinal Panel 2 with […]